Amgen

Amgen is committed to benefiting patients worldwide who suffer from serious diseases by unlocking the potential of biology. To achieve this vision, Amgen has long focused on the exploration, development, manufacturing, and sales of innovative human therapeutics. By leveraging cutting-edge tools such as human genetics, Amgen strives to uncover the complexity of diseases and gain insights into the fundamental mechanisms of human biology.Amgen concentrates on disease areas with significant unmet medical needs, utilizing its advanced expertise in biopharmaceuticals to make outstanding contributions to improving human health and quality of life. Since its founding in 1980, Amgen has become one of the world's leading independent biotechnology companies, providing innovative medicines to millions of patients in over 100 countries and regions globally. Additionally, Amgen has a robust pipeline of promising investigational drugs. Their products address diseases in the fields of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience.